19 completed, 9 unknown, 6 terminated, 4 recruiting. 45 Phase 2, 8 Phase 1, 5 Phase 3.
Follow Corticosteroid: new trials by email Literature Review of Corticosteroid trials Research Report on Corticosteroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-2750 in Participants With Advanced Solid Tumors (MK-2750-002) MK-2750, 5-HT3 serotonin receptor antagonist, NK-1 receptor antagonist - Advanced Solid Tumors, Malignant Neoplasm | Phase 1 / Phase 2 | Not yet recruiting | Merck Sharp & Dohme LLC | 300 | 2026-11-16 | 2026-10-15 |
| Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA) Saline Solution (NaCl 0,9%), Triamcinolone Acetonide - Trapeziometacarpal Osteoarthritis | Phase 2 | Recruiting | Université du Québec à Trois-Rivières | 40 | 2025-11-04 | 2026-08-18 |
| A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) Raludotatug Deruxtecan, Ifinatamab Deruxtecan, Docetetaxel - Carcinoma, Non-Small-Cell Lung | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 96 | 2025-05-13 | 2026-11-06 |
| Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease N-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine Placebo - Lung Cancer, Interstitial Lung Disease | Phase 2 | Recruiting | David Palma | 98 | 2025-01-07 | 2026-08-26 |
| Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis Adalimumab, Prednisone - Inflammatory Arthritis, Immune-related Adverse Event | Phase 2 | Recruiting | Tom Appleton | 30 | 2024-04-15 | 2026-03-03 |
| Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases Azeliragon, Stereotactic radiosurgery, Corticosteroid - Cancer, Metastasis | Phase 1 / Phase 2 | Suspended | Baptist Health South Florida | 46 | 2023-11-17 | 2026-06-16 |
| Treating Exacerbations of Asthma With Oral Montelukast in Children Montelukast Oral Granules, Albuterol, Corticosteroid - Status Asthmaticus | Phase 2 | Completed | Vanderbilt University Medical Center | 90 | 2023-10-20 | 2026-07-02 |
| Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors Itacitinib, Corticosteroid, Endoscopic Procedure - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 2 | Withdrawn | Douglas Johnson | 2023-03-03 | 2026-04-27 | |
| Efficacy of CTM for Tennis ELbow CTM, Celestone - Tennis Elbow, Lateral Epicondylitis \(Tennis Elbow\) | Phase 2 | Unknown | Indiana Hand to Shoulder Center | 54 | 2023-01-26 | 2024-03-27 |
| Mesenchymal Stem Cell Therapy for Knee Osteoarthritis Bone Marrow Derived MSCs, Corticosteroid, Bone Marrow Aspirate - Osteoarthritis, Knee | Phase 1 / Phase 2 | Unknown | Next Generation Regenerative Medicine LLC | 120 | 2022-08-01 | 2022-03-21 |
| Selective CD28 Blockade in Renal Transplant Recipients Lulizumab, Tacrolimus, Thymoglobulin® - Kidney Transplantation, Renal Transplant Recipients | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-01-10 | 2023-03-22 | |
| Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) elotuzumab, placebo for elotuzumab, methylprednisolone - IgG4 Related Disease, IgG4-RD | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2021-10-13 | 2026-02-05 |
| MTX and Steroid for III-IV aGVHD Treatment Methotrexate - Acute Graft Versus Host Disease | Phase 2 | Unknown | Peking University People's Hospital | 30 | 2021-04-21 | 2022-04-20 |
| MTX and Steroid for aGVHD Treatment Methotrexate - Acute GVH Disease | Phase 2 | Unknown | Peking University People's Hospital | 30 | 2020-12-23 | 2021-09-16 |
| Belatacept in De Novo Heart Transplantation Belatacept, Tacrolimus, Mycophenolate Mofetil - Heart Transplantation | Phase 2 | Recruiting | NYU Langone Health | 12 | 2020-08-06 | 2025-12-04 |
| Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee | Phase 2 / Phase 3 | Completed | Queen Savang Vadhana Memorial Hospital, Thailand | 93 | 2020-08-03 | 2023-02-21 |
| Post-operative Corticosteroid Treatment After Mitral Valve Surgery Hydrocortisone, Placebos - Atrial Fibrillation | Phase 2 / Phase 3 | Withdrawn | Kuopio University Hospital | 2020-01-01 | 2022-04-07 | |
| First Line Therapy for High Risk Acute GVHD Ruxolitinib, Corticosteroid - aGVHD, Stem Cell Transplant Complications | Phase 2 | Completed | Chinese PLA General Hospital | 198 | 2019-08-25 | 2023-11-29 |
| Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury Lipogems, Dexamethasone - Spinal Cord Injuries, Tendinopathy | Phase 2 | Unknown | Kessler Foundation | 24 | 2019-06-14 | 2022-10-14 |
| Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses Isoxsuprine Hydrochloride, Placebo, Corticosteroid - Multiple Sclerosis | Phase 1 / Phase 2 | Completed | University of New Mexico | 2 | 2019-02-15 | 2024-02-06 |
Showing 20 of 45. Sign in to see all of them.
Neoplasms (3) · Prostatic Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Lymphoma (2) · Multiple Myeloma (2) · Neoplasm Metastasis (2) · Osteoarthritis (2) · Osteoarthritis, Knee (2) · Rejection, Psychology (2) · Tennis Elbow (2) · Arthritis (1) · Asthma (1) · Atrial Fibrillation (1) · Autoimmune Diseases (1) · Brain Neoplasms (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · H. Lee Moffitt Cancer Center and Research Institute (3) · Celgene (2) · Merck Sharp & Dohme LLC (2) · NYU Langone Health (2) · Peking University People's Hospital (2) · Amgen (1) · Baptist Health South Florida (1) · Chinese PLA General Hospital (1) · Clearside Biomedical, Inc. (1) · David Palma (1) · Dokuz Eylul University (1) · Douglas Johnson (1) · Erasmus Medical Center (1) · Genzyme, a Sanofi Company (1)
United States (23) · Canada (6) · China (5) · Germany (5) · Italy (3) · Spain (3) · Denmark (2) · Finland (2) · Netherlands (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Austria (1) · Brazil (1) · Chile (1) · Estonia (1)
Anant Joshi, Dr. (1) · Andrew B. Adams, MD, PhD (1) · Angeliki Kazeros, MD (1) · Anthony D. Ho, Ph.D., Prof. (1) · Aryeh Fischer, MD (1) · Celeste Bello, M.D. (1) · Christian P. Larsen, MD, DPhil (1) · Christoph Czarnetzki, MD (1) · Colleen Fitzgerald, MD (1) · Corey C Ford, M.D., Ph.D. (1) · Daihong Liu (1) · David B. Badesch, M.D. (1)
PMID 12081113, PMID 1991946, PMID 23406536, PMID 25035839, PMID 25091040, PMID 25161985, PMID 25320358, PMID 25925602, PMID 25963758, PMID 26432430, PMID 27683182, PMID 27980877, PMID 28012636, PMID 28386761, PMID 28469486, PMID 28639856, PMID 28963118, PMID 29885994, PMID 30454753, PMID 30623236, PMID 30632533, PMID 31056949, PMID 32134978, PMID 32960980, PMID 33651671, PMID 33856964, PMID 34107229, PMID 34107236, PMID 34799501, PMID 34826301, PMID 35103547, PMID 35123640, PMID 35503708, PMID 35668528, PMID 38301682, PMID 38829437, PMID 39438467, PMID 42191192
2015 (2), 2016 (1), 2025 (1), U01AI138909 (1), UM1AI144298 (1)